# MyStart Health Review: Care Purpose, Costs and Follow-Up Limits | HealthspanNerds Canonical: https://healthspannerds.com/reviews/mystart-health/ Published: 2026-11-03 Updated: 2026-11-03 Review MyStart Health’s clinical and pharmacy roles, recurring cash-pay costs, refund conflicts, survey limitations and dated FDA advertising warning. [Reviews](https://healthspannerds.com/providers/)/MyStart Health Cash-pay GLP-1 care coordination # MyStart Health review MyStart is a conditional comparison for readers with a defined weight-care need who want clinical access and pharmacy coordination together. I would resolve the actual recurring purchase and prescription refund cutoff before joining. The service and its testimonials do not establish a broader healthspan or longevity benefit. EG[Ellis Grant](https://healthspannerds.com/authors/ellis-grant/)Consumer Editor · Updated November 2026 ## A useful next step? Consider the purpose, the care relationship and the full commitment. Visit MyStart Health↗Official provider website. No affiliate relationship is currently listed. ## A reason to consider it Someone who will use continuing contact and can establish the complete care and payment arrangement. - Independent clinical and pharmacy roles are disclosed. - Follow-up and necessary blood work are included in the homepage programme description. - Monthly and three-month renewals are differentiated. ## What deserves scrutiny A reader treating a weight-loss testimonial as evidence of better function or longer life. - Selected treatment total needs a written quote. - Prescription and shipment refund boundaries conflict. - Brand-name cards contradict the phone page’s own disclaimer. - Customer survey results do not demonstrate a healthspan benefit. ## Give the recurring service a defined purpose MyStart coordinates clinical review, continuing contact and prescription fulfillment. Its programme can be a useful comparison when a reader needs those services together. That purchase should start with an existing weight-care need, rather than an expectation that any weight-loss service constitutes a prevention or longevity programme. [\[1\]](https://healthspannerds.com/reviews/mystart-health/#reference-1) The platform says it neither makes treatment decisions nor dispenses medication. Independent licensed clinicians and pharmacies fill those roles. I would want the responsible clinical team and actual pharmacy clear before judging how well this arrangement complements existing care. A single commercial interface does not make those responsibilities interchangeable. [\[1\]](https://healthspannerds.com/reviews/mystart-health/#reference-1) Keep the actual outcome in context with [the weight, lean-mass and function review](https://healthspannerds.com/research/weight-loss-lean-mass-function/). ## Judge the full purchase rather than the opening saving The homepage FAQ starts the programme at $299 per month before discounts, with evaluations, follow-up, prescribed medicine, necessary blood work and shipping described as included. It distinguishes monthly renewal from a three-month charge and supply. The actual formulation, amount supplied and recurring total still need to appear in the selected quote. [\[1\]](https://healthspannerds.com/reviews/mystart-health/#reference-1) The base-plan price-lock promise excludes the first-time discount. Meanwhile, the homepage says no membership fees and the refund policy describes a monthly membership supporting users regardless of prescribing. That needs reconciliation; it does not justify adding an imagined second fee or assuming every displayed price buys the same care. [\[1\]](https://healthspannerds.com/reviews/mystart-health/#reference-1) [\[2\]](https://healthspannerds.com/reviews/mystart-health/#reference-2) Put the selected charges and payment periods together in [the annual care-cost planner](https://healthspannerds.com/tools/cost-planner/). ## A product card does not establish the prescription The public phone page displays a compounded-tirzepatide starting promotion of $279 against $399, without a clear card interval. Its separate Wegovy and Ozempic cards are followed by a disclosure expressly saying those branded products are not offered. I would not use those cards as evidence of current branded access or a monthly treatment total. [\[4\]](https://healthspannerds.com/reviews/mystart-health/#reference-4) The compounded preparations identified in MyStart’s disclosures are not FDA-approved. A reader needs the proposed preparation and reason for selecting it from the clinician, rather than assuming a familiar ingredient name supplies the same evidence as an approved finished medicine. [\[6\]](https://healthspannerds.com/reviews/mystart-health/#reference-6) For a separate compounded-care arrangement, read [our Sprout Health review](https://healthspannerds.com/reviews/sprout-health/). ## The refund boundary should be settled before payment The December 2025 policy provides a specific full-refund exception for medical ineligibility with no prescription issued and no medicine shipped. It separately permits cancellation before pharmacy fulfillment, yet another section excludes refunds if a prescription has been written. That is a meaningful uncertainty before the first payment. [\[2\]](https://healthspannerds.com/reviews/mystart-health/#reference-2) After shipment, the policy rejects cancellation, medication returns and refunds; completed or partly completed membership periods are also excluded. The homepage’s cancel-anytime wording should therefore be read as a route to request cancellation, not a universal trial guarantee. Clinical follow-up and future subscriptions need separate attention when care is changing. [\[1\]](https://healthspannerds.com/reviews/mystart-health/#reference-1) [\[2\]](https://healthspannerds.com/reviews/mystart-health/#reference-2) Compare a different membership and refund model in [our Zealthy review](https://healthspannerds.com/reviews/zealthy/). ## Separate customer stories from clinical evidence The homepage qualifies its results as a sixteen-customer survey with self-reported experiences that are not typical. That cannot establish preserved function, prevention of disease or longer life from buying this service. It also cannot tell a reader which support package will fit a different medical situation. [\[1\]](https://healthspannerds.com/reviews/mystart-health/#reference-1) FDA’s September 9, 2025 warning concerned advertising implying compounded semaglutide was the same as approved medicine. The dated letter does not establish subsequent resolution, contamination or a particular patient outcome. Its relevance is the product-evidence boundary, not a basis for inventing a new clinical safety finding. [\[5\]](https://healthspannerds.com/reviews/mystart-health/#reference-5) Keep the product and purpose visible in [our service comparisons](https://healthspannerds.com/compare/). ## Use continuing contact to solve a real gap MyStart’s programme FAQ describes access to clinicians and follow-up without an extra consultation charge. That can matter if the arrangement supplies contact a reader would otherwise lack. It does not establish a guaranteed response time, universal availability or a prescription following a preliminary screen. [\[1\]](https://healthspannerds.com/reviews/mystart-health/#reference-1) I would compare MyStart once the clinical responsibility, recurring quote and refund cutoff are clear. LifeMD is a separate clinical-access alternative with its own medicine and fee structure. A reader who already has adequate prescribing support may need a narrower pharmacy or cost comparison instead of another ongoing service. For the separate clinical-access comparison, see [our LifeMD review](https://healthspannerds.com/reviews/lifemd/). Compare a different ongoing clinical-and-behavioral arrangement in [our Found review](https://healthspannerds.com/reviews/found/). For a separate coordinated-care purchase and its longer-plan terms, read [our TMates review](https://healthspannerds.com/reviews/tmates/). ## Understanding the cost Homepage FAQ starts the programme at $299/month before discounts and describes monthly or three-month renewal. Actual selected medicine, supply, promotion and recurring total require a written quote. Separate phone page advertises compounded tirzepatide $279 against $399 without a clear card interval; do not treat that as a monthly complete-care price. Brand-name cards conflict with that page’s express no-Wegovy/no-Ozempic disclosure. Refund cutoff wording conflicts between prescription issuance and fulfillment/shipment. [\[1\]](https://healthspannerds.com/reviews/mystart-health/#reference-1) [\[2\]](https://healthspannerds.com/reviews/mystart-health/#reference-2) [\[3\]](https://healthspannerds.com/reviews/mystart-health/#reference-3) [\[4\]](https://healthspannerds.com/reviews/mystart-health/#reference-4) [Build your cost estimate](https://healthspannerds.com/tools/cost-planner/) ## Read alongside this review [the weight, lean-mass and function review](https://healthspannerds.com/research/weight-loss-lean-mass-function/)Keep the studied outcome distinct from a care-service promise. ## Sources - MyStart: programme pricing, renewals and independent-care disclosures - MyStart: December 1, 2025 refund and fulfillment policy - MyStart: February 1, 2026 terms and payment scope - MyStart: public phone-offer cards and brand-name exclusion - FDA: September 9, 2025 MyStart advertising warning - MyStart: compounded-product and results disclosures This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.